GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bafna Pharmaceuticals BAFNAPH.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

472.80

+4.03%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹1.51bn

FY2017FY2026

Net income

₹111.0m

FY2017FY2026

Free cash flow

−₹130.8m

FY2017FY2026

Shareholders' equity

₹961.5m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹1.51bn₹1.46bn₹1.52bn₹1.15bn₹851.4m₹712.2m₹424.7m₹436.3m₹471.7m₹649.6m
Research and development₹14.5m₹21.9m₹15.4m₹7.2m₹14.7m₹13.6m₹10.1m₹7.5m₹3.7m₹7.2m
Operating income₹98.8m₹62.9m₹96.4m₹124.3m₹65.0m₹58.5m−₹19.6m−₹68.6m−₹77.7m−₹203.6m
Net income₹111.0m₹41.5m₹73.5m₹113.4m₹52.2m₹58.3m−₹18.8m−₹188.7m−₹167.4m−₹190.9m
Diluted earnings per share4.431.763.104.782.192.46-0.79-7.98-7.07-7.62

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹1.76bn₹1.53bn₹1.48bn₹1.30bn₹901.4m₹864.7m₹713.1m₹1.19bn₹1.38bn₹1.78bn
Cash and short-term investments₹20.2m₹34.3m₹14.0m₹78.1m₹194,000₹18.0m₹81.9m₹27.1m₹29.5m₹4.4m
Total liabilities₹793.8m₹682.7m₹668.4m₹561.3m₹281.8m₹296.9m₹201.2m₹1.01bn₹1.01bn₹1.36bn
Debt₹374.3m₹282.0m₹243.9m₹229.2m₹110.6m₹130.0m₹30.2m₹462.3m₹465.4m₹823.8m
Shareholders' equity₹961.5m₹848.1m₹808.4m₹734.5m₹619.6m₹567.7m₹511.1m₹190.6m₹379.3m₹426.7m
Shares outstanding25m24m24m24m24m24m24m24m24m25m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹118.3m₹195.3m₹94.8m₹49.5m₹97.3m−₹136.1m−₹342.7m−₹17.9m−₹70.5m−₹9.5m
Capital spending−₹249.0m−₹218.6m−₹155.8m−₹82.2m−₹75.4m−₹60.9m−₹14.3m−₹3.3m−₹1.3m−₹791,000
Free cash flow−₹130.8m−₹23.3m−₹60.9m−₹32.7m₹21.9m−₹197.0m−₹357.0m−₹21.2m−₹71.7m−₹10.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹284.9m₹422.4m₹382.9m₹354.7m₹346.2m₹390.6m₹331.9m₹403.2m
Operating income₹53.8m₹18.9m₹14.8m₹28.1m₹37.0m₹29.0m₹14.1m₹22.2m
Net income₹751,000₹27.5m₹18.4m₹31.2m₹33.9m₹13.1m₹9.5m₹26.2m
Diluted earnings per share0.031.100.781.321.430.550.401.10
Cash from operations———₹93.0m————
Capital spending———−₹164.0m————
Free cash flow———−₹71.0m————
Total assets—₹1.76bn—₹1.61bn—₹1.53bn—₹1.34bn
Cash and short-term investments₹20.2m₹20.2m₹2.5m₹19.7m₹34.3m₹34.3m₹13.1m₹13.2m
Debt—₹374.3m—₹324.0m—₹282.0m—₹188.2m
Shareholders' equity₹961.5m₹961.5m₹912.3m₹912.3m₹848.1m₹848.1m₹827.5m₹827.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.3%16.2%5.8%
Operating income-7.4%11.0%—
Net income-0.7%13.8%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin5.5%6.8%7.0%-0.2%
Net margin5.1%6.0%6.2%-2.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings99.085.925.419.345.961.9-215.6-0.5-1.6-3.7
Price to sales7.32.41.21.92.85.19.50.20.61.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 19 Sept 2013.

FY2014
Paid in the year6.00
  • 100-to-10 reverse split · 26 Aug 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.